-
Contract Timeline
- Publication Date
-
2nd October 2024 15:31:07 PM
-
Contract Summary
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. -
Contract Details
- Open Contracting ID
-
ocds-h6vhtk-045808
- Publication Source
-
Find a Tender Service
- Procurement Stage
-
TenderUpdate
- Procurement Method
-
N/A
- Procurement Method Details
-
N/A
- Procurement Category
-
Services
- Tender Suitability
-
- Framework / DPS
-
Contract Classification
- CPV Code(s)
-
85100000
- CPV Division(s)
-
85 - Health and social work services
-
Awarding Authority
- Buyer Name
-
Leigh Parker
- Buyer Email
-
leigh.parker1@nhs.net
- Buyer Phone
- Buyer Address
-
7-8 Wellington Place
Leeds
LS1 4AP
United Kingdom
-
Contract Timeline
- Publication Date
-
5th September 2024 18:21:47 PM
- Tender Deadline
-
7th October 2024 11:00:00 AM Expired
-
Contract Summary
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. -
Contract Details
- Open Contracting ID
-
ocds-h6vhtk-045808
- Publication Source
-
Find a Tender Service
- Procurement Stage
-
Tender
- Procurement Method
-
Open
- Procurement Method Details
-
Open Procedure
- Procurement Category
-
Services
- Tender Suitability
-
- Framework / DPS
-
Contract Classification
- CPV Code(s)
-
85100000
- CPV Division(s)
-
85 - Health and social work services
-
Awarding Authority
- Buyer Name
-
Leigh Parker
- Buyer Email
-
leigh.parker1@nhs.net
- Buyer Phone
- Buyer Address
-
7-8 Wellington Place
Leeds
LS1 4AP
United Kingdom
-
Contract Timeline
- Publication Date
-
2nd July 2024 16:16:20 PM
-
Contract Summary
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. -
Contract Details
- Open Contracting ID
-
ocds-h6vhtk-045808
- Publication Source
-
Find a Tender Service
- Procurement Stage
-
TenderUpdate
- Procurement Method
-
N/A
- Procurement Method Details
-
N/A
- Procurement Category
-
Services
- Tender Suitability
-
- Framework / DPS
-
Contract Classification
- CPV Code(s)
-
85100000
- CPV Division(s)
-
85 - Health and social work services
-
Awarding Authority
- Buyer Name
-
Leigh Parker
- Buyer Email
-
england.commercialqueries@nhs.net
- Buyer Phone
- Buyer Address
-
1st Floor, Quarry House, Quarry Hill
Leeds
LS2 7UE
United Kingdom
-
Contract Timeline
- Publication Date
-
19th June 2024 15:45:24 PM
- Tender Deadline
-
31st July 2024 11:00:00 AM Expired
-
Contract Summary
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. -
Contract Details
- Open Contracting ID
-
ocds-h6vhtk-045808
- Publication Source
-
Find a Tender Service
- Procurement Stage
-
Tender
- Procurement Method
-
Open
- Procurement Method Details
-
Open Procedure
- Procurement Category
-
Services
- Tender Suitability
-
- Framework / DPS
-
Contract Classification
- CPV Code(s)
-
85100000
- CPV Division(s)
-
85 - Health and social work services
-
Awarding Authority
- Buyer Name
-
Leigh Parker
- Buyer Email
-
england.commercialqueries@nhs.net
- Buyer Phone
- Buyer Address
-
7-8 Wellington Place
Leeds
LS1 4AP
United Kingdom
-
Contract Timeline
- Publication Date
-
8th May 2024 14:33:42 PM
-
Contract Summary
NHS England has published this Prior Information Notice (PIN) in relation to securing a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
NHS England would like to gather soft intelligence from the market and is publishing a Request for Information.
The Request for Information and further documentation will be available from 8 May 2024 and the deadline for responses will be 12 noon on 22 May 2024.
To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. -
Contract Details
- Open Contracting ID
-
ocds-h6vhtk-045808
- Publication Source
-
Find a Tender Service
- Procurement Stage
-
Planning
- Procurement Method
-
N/A
- Procurement Method Details
-
N/A
- Procurement Category
-
Services
- Tender Suitability
-
- Framework / DPS
-
Contract Classification
- CPV Code(s)
-
85149000
- CPV Division(s)
-
85 - Health and social work services
-
Awarding Authority
- Buyer Name
-
Leigh Parker
- Buyer Email
-
england.commercialqueries@nhs.net
- Buyer Phone
- Buyer Address
-
7-8 Wellington Place
Leeds
LS1 4AP
United Kingdom